Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-23 5:08 pm Sale | 2025-06-18 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 14,534 1.000% | -79,559 (-84.55%) | Filing History |
| 2025-06-23 5:06 pm Sale | 2025-06-18 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 242,452 4.800% | -222,775 (-47.89%) | Filing History |
| 2024-09-16 4:34 pm Sale | 2024-09-12 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 465,227 9.990% | -102,296 (-18.03%) | Filing History |
| 2024-07-17 8:40 pm Purchase | 2024-07-15 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 94,093 9.990% | 27,894 (+42.14%) | Filing History |
| 2024-03-19 9:11 pm Purchase | 2024-03-15 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 66,199 19.900% | 41,979 (+173.32%) | Filing History |
| 2024-03-11 7:19 pm Unchanged | 2024-03-11 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 567,523 16.000% | 0 (Unchanged) | Filing History |
| 2024-03-08 4:30 pm Purchase | 2024-03-06 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 24,220 9.900% | 254 (+1.06%) | Filing History |
| 2023-11-15 4:35 pm Unchanged | 2023-11-14 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 567,523 18.300% | 0 (Unchanged) | Filing History |
| 2023-05-08 4:43 pm Purchase | 2023-05-04 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 23,966 9.900% | 5,353 (+28.76%) | Filing History |
| 2023-03-17 4:19 pm Purchase | 2023-02-27 | 13D | BiomX Inc. PHGE | OrbiMed Israel BioFund GP Limited Partnership | 18,613 10.500% | 6,558 (+54.40%) | Filing History |
| 2023-01-05 4:31 pm Sale | 2023-01-03 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 567,523 19.700% | -12,467,432 (-95.65%) | Filing History |
| 2022-07-01 5:20 pm Sale | 2022-07-01 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 12,356,873 4.600% | -3,027,545 (-19.68%) | Filing History |
| 2021-06-28 5:24 pm Sale | 2021-06-24 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 15,384,418 6.000% | -17,118,837 (-52.67%) | Filing History |
| 2021-04-07 4:46 pm Unchanged | 2021-04-05 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 13.200% | 0 (Unchanged) | Filing History |
| 2021-03-26 4:06 pm Purchase | 2021-03-16 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 13,034,955 24.300% | 13,034,955 (New Position) | Filing History |
| 2021-03-25 5:26 pm Unchanged | 2021-03-22 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 14.600% | 0 (Unchanged) | Filing History |
| 2021-01-05 4:38 pm Unchanged | 2020-12-22 | 13D | NOVUS THERAPEUTICS INC NVUS | OrbiMed Israel BioFund GP Limited Partnership | 73,650 0.500% | 0 (Unchanged) | Filing History |